IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i14p7679-d597307.html
   My bibliography  Save this article

Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data

Author

Listed:
  • Andrea Spini

    (INSERM, BPH, U1219, Team Pharmacoepidemiology, University of Bordeaux, 33000 Bordeaux, France
    Department of Medical Science, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy)

  • Giulia Hyeraci

    (Osservatorio di Epidemiologia, Agenzia Regionale di Sanità Della Toscana, 50141 Florence, Italy)

  • Claudia Bartolini

    (Osservatorio di Epidemiologia, Agenzia Regionale di Sanità Della Toscana, 50141 Florence, Italy)

  • Sandra Donnini

    (Department of Life Sciences, University of Siena, 53100 Siena, Italy)

  • Pietro Rosellini

    (CIC1401, CIC Bordeaux, 33000 Bordeaux, France
    Pole de Santé Publique, Service de Pharmacologie Médicale, Centre de Pharmacovigilance de Bordeaux, CHU de Bordueax, 33000 Bordeaux, France)

  • Rosa Gini

    (Osservatorio di Epidemiologia, Agenzia Regionale di Sanità Della Toscana, 50141 Florence, Italy)

  • Marina Ziche

    (Department of Medical Science, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy)

  • Francesco Salvo

    (INSERM, BPH, U1219, Team Pharmacoepidemiology, University of Bordeaux, 33000 Bordeaux, France
    Pole de Santé Publique, Service de Pharmacologie Médicale, Centre de Pharmacovigilance de Bordeaux, CHU de Bordueax, 33000 Bordeaux, France)

  • Giuseppe Roberto

    (Osservatorio di Epidemiologia, Agenzia Regionale di Sanità Della Toscana, 50141 Florence, Italy)

Abstract

Routinely collected electronic healthcare data (rcEHD) have a tremendous potential for enriching pre-marketing evidence on target- and immunotherapies used to treat lung cancer (LC). A scoping review was performed to provide a structured overview of available rcEHD-based studies on this topic and to support the execution of future research by facilitating access to pertinent literature both for study design and benchmarking. Eligible studies published between 2016 and 2020 in PubMed and ISI Web of Science were searched. Data source and study characteristics, as well as evidence on drug utilization and survival were extracted. Thirty-two studies were included. Twenty-six studies used North American data, while three used European data only. Thirteen studies linked ≥1 data source types among administrative/claims data, cancer registries and medical/health records. Twenty-nine studies retrieved cancer-related information from medical records/cancer registries and 31 studies retrieved information on drug utilization or survival from medical records or administrative/claim data. Most part of studies concerned non-small-cell-LC patients (29 out of 32) while none focused on small-cell-LC. Study cohorts ranged between 85 to 81,983 patients. Only two studies described first-line utilization of immunotherapies. Results from this review will serve as a starting point for the execution of future rcEHD-based studies on innovative LC pharmacotherapies.

Suggested Citation

  • Andrea Spini & Giulia Hyeraci & Claudia Bartolini & Sandra Donnini & Pietro Rosellini & Rosa Gini & Marina Ziche & Francesco Salvo & Giuseppe Roberto, 2021. "Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data," IJERPH, MDPI, vol. 18(14), pages 1-21, July.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:14:p:7679-:d:597307
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/14/7679/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/14/7679/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Corinne Willame & Caitlin Dodd & Lieke van der Aa & Gino Picelli & Hanne-Dorthe Emborg & Johnny Kahlert & Rosa Gini & Consuelo Huerta & Elisa Martín-Merino & Chris McGee & Simon Lusignan & Giuseppe Ro, 2021. "Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project," Drug Safety, Springer, vol. 44(3), pages 383-395, March.
    2. Kurt Benke & Geza Benke, 2018. "Artificial Intelligence and Big Data in Public Health," IJERPH, MDPI, vol. 15(12), pages 1-9, December.
    3. Giuseppe Roberto & Ingrid Leal & Naveed Sattar & A Katrina Loomis & Paul Avillach & Peter Egger & Rients van Wijngaarden & David Ansell & Sulev Reisberg & Mari-Liis Tammesoo & Helene Alavere & Alessan, 2016. "Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project," PLOS ONE, Public Library of Science, vol. 11(8), pages 1-18, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Claus Zippel & Sabine Bohnet-Joschko, 2021. "Rise of Clinical Studies in the Field of Machine Learning: A Review of Data Registered in ClinicalTrials.gov," IJERPH, MDPI, vol. 18(10), pages 1-14, May.
    2. Likeng Liang & Jifa Hu & Gang Sun & Na Hong & Ge Wu & Yuejun He & Yong Li & Tianyong Hao & Li Liu & Mengchun Gong, 2022. "Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources," Drug Safety, Springer, vol. 45(5), pages 511-519, May.
    3. Wen-Yu Ou Yang & Cheng-Chien Lai & Meng-Ting Tsou & Lee-Ching Hwang, 2021. "Development of Machine Learning Models for Prediction of Osteoporosis from Clinical Health Examination Data," IJERPH, MDPI, vol. 18(14), pages 1-12, July.
    4. Lester Darryl Geneviève & Andrea Martani & Maria Christina Mallet & Tenzin Wangmo & Bernice Simone Elger, 2019. "Factors influencing harmonized health data collection, sharing and linkage in Denmark and Switzerland: A systematic review," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-44, December.
    5. Julien Issa & Raphael Olszewski & Marta Dyszkiewicz-Konwińska, 2022. "The Effectiveness of Semi-Automated and Fully Automatic Segmentation for Inferior Alveolar Canal Localization on CBCT Scans: A Systematic Review," IJERPH, MDPI, vol. 19(1), pages 1-10, January.
    6. Heather Behr & Annabell Suh Ho & Ellen Siobhan Mitchell & Qiuchen Yang & Laura DeLuca & Andreas Michealides, 2021. "How Do Emotions during Goal Pursuit in Weight Change over Time? Retrospective Computational Text Analysis of Goal Setting and Striving Conversations with a Coach during a Mobile Weight Loss Program," IJERPH, MDPI, vol. 18(12), pages 1-15, June.
    7. Daniele Piovani & Stefanos Bonovas, 2022. "Real World—Big Data Analytics in Healthcare," IJERPH, MDPI, vol. 19(18), pages 1-3, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:14:p:7679-:d:597307. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.